Author/Authors :
Frizzelli, Annalisa Department of Medicine and Surgery - Respiratory Disease and Lung Function Unit - University of Parma, Parma, Italy , Tuttolomondo, Domenico Department of Medicine and Surgery - Respiratory Disease and Lung Function Unit - University of Parma, Parma, Italy , Aiello, Marina Department of Medicine and Surgery - Respiratory Disease and Lung Function Unit - University of Parma, Parma, Italy , Majori, Maria Department of Cardiothoracic and Vascular Diseases - Pneumology and Endothoracic Endoscopy Unit - University Hospital, Parma, Italy , Bertorelli, Giuseppina Department of Medicine and Surgery - Respiratory Disease and Lung Function Unit - University of Parma, Parma, Italy , Chetta, Alfredo Department of Medicine and Surgery - Respiratory Disease and Lung Function Unit - University of Parma, Parma, Italy
Abstract :
The novel coronavirus SARS-CoV-2 was first identified in Wuhan in December 2019 as cause of the consequent novel coronavirus disease 2019 (COVID-19). The virus has since spread worldwide. The clinical presentation following human infection ranges from a mild upper respiratory tract infection to severe acute res-piratory distress syndrome and sepsis. We reviewed literature using Pubmed to identify relevant English-language articles published until April 15, 2020. Search terms include novel coronavirus pneumonia, severe acute respiratory syndrome coronavirus 2, coronavirus and ventilation. We summarized what SARS-CoV-2 infection means for the lungs. (www.actabiomedica.it)
Keywords :
SARS-CoV-2 , Pneumonia , Respiratory failure , ARDS
